September 16, 2014

The Natural Products Association on Monday announced it has signed 127 new members since naming Daniel Fabricant executive director and CEO in April. 

April 8, 2014

The Natural Products Association on Tuesday named Daniel Fabricant the association's new CEO.

November 20, 2013

Following actions by the Food and Drug Administration, USPLabs has agreed to recall and destroy the dietary supplement OxyElite Pro, as it has been linked to dozens of cases of acute liver failure and hepatitis, including one death and illnesses so severe that several patients required liver transplants, the agency noted Wednesday.

July 19, 2013

The Council for Responsible Nutrition announced that Daniel Fabricant, director of the Division of Dietary Supplement Programs at the Food and Drug Administration, will be a keynote speaker at The Conference: CRN’s Annual Symposium for the Dietary Supplement Industry Sept. 18 to 21 in Park City, Utah.

July 13, 2012

The dietary supplement industry recently responded to a Senate query around why the dietary supplement industry is failing to live up to Food and Drug Administration regulations.

September 30, 2011

The New Dietary Ingredient draft guidance, which recently was issued by the Food and Drug Administration, is causing a stir within the dietary supplement industry as experts continue to evaluate what kind of impact the guidance will have on their businesses.

July 27, 2011

The Council for Responsible Nutrition on Wednesday announced that Daniel Fabricant, director of the Division of Dietary Supplement Programs at the Food and Drug Administration, will deliver the keynote address at The Conference: CRN’s Annual Symposium for the Dietary Supplement Industry on Oct. 20 in Rancho Palos Verdes, Calif.

February 2, 2011

One of the more recognizable faces of the Natural Products Association will be leaving association work in favor of the Food and Drug Administration, Drug Store News learned Wednesday.

October 4, 2009

Here’s the breakdown: Two government officials representing the Food and Drug Administration and the Drug...